TSX:EXEHealthcare
Extendicare Q4 FFO Stability Tests Bullish Earnings Growth Narratives
Extendicare (TSX:EXE) has wrapped up FY 2025 with fourth quarter revenue of $462.0 million and basic EPS of $0.29, setting the tone for how investors interpret the full year. Over the past six quarters, the company has seen quarterly revenue move from $359.1 million in Q3 2024 to $462.0 million in Q4 2025. Over the same period, basic EPS has ranged between $0.19 and $0.38, giving a sense of how the top and bottom lines have tracked together. With trailing twelve month EPS at $1.13 and net...